Supervised oral protein supplementation during dialysis in patients with elevated C-reactive protein levels: a two phase, longitudinal, single center, open labeled study

Table 2 Weekly average of supervised protein supplementation during dialysis in the interventional period

Week	N	N non-adherent^a	g/week	g/kg/d
13	46	2 (4.3 %)	118.0 ± 32.2	0.21 ± 0.07
14	45	3 (6.7 %)	117.0 ± 37.6	0.21 ± 0.07
15	45	7 (15.6 %)	106.3 ± 47.4	0.18 ± 0.09
16	45	7 (15.6 %)	101.7 ± 51.6	0.18 ± 0.10
17	45	7 (15.6 %)	95.0 ± 51.7	0.16 ± 0.09
18	44	8 (18.2 %)	94.8 ± 51.9	0.16 ± 0.10
19	44	6 (13.6 %)	108.1 ± 46.4	0.19 ± 0.09
20	44	6 (13.6 %)	107.4 ± 48.7	0.18 ± 0.09
21	42	6 (14.3 %)	103.9 ± 50.2	0.18 ± 0.09
22	42	7 (16.7 %)	105.0 ± 52.3	0.18 ± 0.10
23	42	8 (19.0 %)	97.5 ± 53.4	0.17 ± 0.10
24	41	8 (19.5 %)	86.0 ± 57.1	0.15 ± 0.10

^aNon-adherence to intervention was defined as consumption of < 50 % of provided protein supplement or continuing in the study after stopping the intervention

ISSN: 1471-2369